echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Phytomedicine: Zishen Pills Relieve Diabetes-Related Cognitive Impairment

    Phytomedicine: Zishen Pills Relieve Diabetes-Related Cognitive Impairment

    • Last Update: 2022-04-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Background: Diabetic cognitive impairment (DCI) is prevalent in patients with diabetes, but its underlying mechanism is unclear and there are no better therapeutic drugs
    .
    Skeletal muscle is an important pathological organ of diabetes


    .


    Diabetic Cognitive Impairment (DCI) Diabetic Cognitive Impairment (DCI) Skeletal Muscle Skeletal Muscle Kynurenine (KYN) Kynurenine (KYN) KYNA KYNA KATs KATs PGC-1α-PPARα PGC-1α-PPARα PGC- 1α-KYN pathway PGC-1α-KYN pathway

    In Chinese medicine, the main pathogenesis of DCI is "toxin damages the brain and collaterals " and " deficiency of kidney essence ", while " clearing heat and detoxifying " and " tonifying kidney and preserving essence " are the main treatment principles
    .
    Tongguan Pill (TGW) , also known as Zishen Pill (ZSW) or Zishen Tongguan Pill, is recorded in Li Dongyuan's "Orchid Secret Collection" in the Yuan Dynasty.



    Toxin damages the brain and collaterals Toxin damages the brain collaterals and kidney essence Deficiency Kidney essence deficiency Clears heat and detoxification , clears heat and detoxifies the kidney, protects the essence , nourishes the kidney and protects the Jing Tongguan Pill (TGW) Clearance Pill (TGW) Zishen Pill (ZSW) Zishen Pill (ZSW) Enhanced Kidney- tonifying effect enhanced kidney-tonifying effect Zishen Wanfang (ZSWF) Zishen Wanfang (ZSWF)

    Objective: From the perspective of peripheral skeletal muscle and brain communication, to explore the effect of ZSWF on the cognitive function of DCI mice and its mechanism, and to provide new strategies and prescriptions for clinical prevention and treatment of DCI
    .

    Effects of ZSWF on Cognitive Function of DCI Mice Effects of ZSWF on Cognitive Function of DCI Mice

    Methods: DCI was induced by intraperitoneal injection of streptozotocin (STZ) combined with a high-fat diet , and ZSWF extracts of different doses were administered orally for 8 weeks, once a day
    .
    Cognitive function (water maze test) and skeletal muscle function ( grip test, muscle weight, HE-stained quadriceps cross section) were assessed, and synaptic plasticity was measured ( synaptophysin SYN, postsynaptic density protein PSD-95 expression in the hippocampus of DCI mice) and type 1 amino acid transporter (LAT1)


    .


    Intraperitoneal injection of streptozotocin (STZ) combined with high-fat diet Intraperitoneal injection of streptozotocin (STZ) combined with high-fat diet cognitive function cognitive function Its metabolites and metabolic enzymes KYN and its metabolites and metabolic enzymes PGC-1α PGC-1α PPARα PPARα

    RESULTS: Compared with healthy mice, DCI mice exhibited cognitive decline and abnormal skeletal muscle function, as well as imbalance of KYN metabolism in brain, circulating blood, and skeletal muscle
    .
    Cognitive function, synaptic plasticity, and skeletal muscle function were significantly attenuated in DCI mice 8 weeks after ZSWF administration


    .


    Conclusion: The above results indicate that KYN metabolism disorder mediated by abnormal skeletal muscle PGC1α-PPARα signaling is one of the pathological mechanisms of DCI.
    ZSWF can increase the expression of skeletal muscle KATs and maintain the stability of KYN metabolism by activating skeletal muscle PGC1α-PPARα signaling.
    state, and ultimately improve synaptic plasticity and improve cognitive performance .
    This provides some theoretical support for ZSWF clinical treatment of DCI .

    Skeletal muscle PGC1α-PPARα signaling abnormal Skeletal muscle PGC1α-PPARα signaling abnormal KYN metabolic disorder KYN metabolic disorder

     

    Source:

    Source:

    Yin Q, Zhang L, Han X, et al.
    Zi Shen Wan Fang regulates kynurenine metabolism to alleviate diabetes-associated cognitive impairment via activating the skeletal muscle PGC1α-PPARα signaling [published online ahead of print, 2022 Feb 22].
    Phytomedicine .


    2022 ;99:154000.
    doi:10.


    Yin Q, Zhang L, Han X, et al.
    Zi Shen Wan Fang regulates kynurenine metabolism to alleviate diabetes-associated cognitive impairment via activating the skeletal muscle PGC1α-PPARα signaling [published online ahead of print, 2022 Feb 22].
    Phytomedicine .
    2022 ;99:154000.
    doi:10.
    1016/j.
    phymed.
    2022.
    154000 Phytomedicine commented here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.